CD PROJEKT SA (0LX1)
London Exchange · UK · prices in PLN · close of 20 Oct 2026
Key indicators
| Last close | PLN 99.00 |
|---|---|
| 52-week range | 99.00 – 254.60 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | +0.0% / +2.1% |
| Trend | Below its 200-day average |
| RSI (14) | 100 |
| Volatility (1 year) | 0.0% |
| Worst drawdown (1 year) | 0.0% |
| Average daily value traded | 0.04M PLN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CD Projekt is a video game developer and publisher based in Poland. The company creates role-playing games, most notably the Witcher series and Cyberpunk, and it also runs a digital storefront that offers games for personal computers. Its customers are players around the world who buy its titles and use its online store, and the company works with outside studios whose games it publishes. CD Projekt develops and releases its own games and supports them with expansions and updates after launch.
CD PROJEKT SA trades under the code 0LX1 on the London Exchange in UK, with its price quoted in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CD PROJEKT SA (0LX1) trades on the London Exchange in UK. It last closed at PLN 99.00 on 20 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,222 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.0% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.0% | ||
| From 52-week high | 0.0% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 0.0% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 0.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | 0.0% | ||
| Liquidity | 15 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.04M PLN | ||
| Zero-volume days | 96.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | +0.0% |
| 1 year | +0.0% |
| 3 years | +2.1% |
| 5 years | +4.1% |
Signals
| 50-day / 200-day average | 99.00 / 99.00 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 27.83 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Jun 2025 | PLN 1.0000 |
| 20 Jun 2024 | PLN 1.0000 |
| 12 Jun 2023 | PLN 1.0000 |
| 4 Jul 2022 | PLN 1.0000 |
| 31 May 2021 | PLN 5.0000 |
| 30 May 2019 | PLN 1.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.